Somerville, MA, United States of America

Anne-Laure Grillot

USPTO Granted Patents = 36 

 

 

Average Co-Inventor Count = 8.4

ph-index = 13

Forward Citations = 379(Granted Patents)


Location History:

  • Somerville, MA (US) (2011 - 2013)
  • Cambridge, MA (US) (2003 - 2014)
  • Milton, MA (US) (2013 - 2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents

Title: **The Innovative Work of Anne-Laure Grillot in the Field of Pharmaceutical Patents**

Introduction

Anne-Laure Grillot, based in Somerville, MA, is a distinguished inventor with an impressive portfolio of 36 patents. Her work primarily focuses on pharmaceutical innovations aimed at treating various diseases, particularly demyelinating and neurodegenerative disorders. Grillot's inventive contributions have significant implications for medical research and therapeutic applications.

Latest Patents

Two of her latest patents illustrate the depth of her research endeavors. The first patent, titled "Triazoles for the Treatment of Demyelinating Diseases", involves triazole compounds that act as modulators for demyelinating diseases, including multiple sclerosis. This invention not only showcases her innovative approach but also includes pharmaceutically acceptable compositions and methods for treatment related to these conditions.

The second patent, "Isoindolinone Inhibitors of Phosphatidylinositol 3-Kinase", relates to compounds that effectively inhibit PI3K, particularly the PI3Kγ isoform. This patent emphasizes innovative therapeutic options for various diseases, conditions, or disorders by providing methods and compositions for treatment using these compounds.

Career Highlights

Throughout her career, Anne-Laure Grillot has made notable contributions to pharmaceutical sciences, particularly during her time at Vertex Pharmaceuticals, Inc. and Spero Trinem, Inc. Her work at these companies has helped advance the development of impactful medical treatments that benefit patients worldwide.

Collaborations

Collaboration has played a significant role in Grillot's innovative journey. She has worked closely with esteemed colleagues such as Paul S. Charifson and Yusheng Liao. These partnerships reflect her commitment to interdisciplinary research, which is essential for fostering innovation in the pharmaceutical industry.

Conclusion

Anne-Laure Grillot's extensive contributions to the field of pharmaceutical patents underscore her role as a leading innovator in medical research. Her latest inventions reveal a dedication to addressing critical health challenges, paving the way for new treatment modalities in demyelinating and neurodegenerative diseases. As her career continues to evolve, her work promises to improve patient outcomes and contribute to the ongoing evolution of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…